Condition: Right Bundle-Branch Block · Heart Failure · His-bundle Pacing · Sponsor: University of Rochester
The investigators aim to prospectively evaluate the efficacy and mechanism of benefit of His-bundle pacing enhanced cardiac resynchronization therapy (His-CRT) vs. cardiac resynchronization therapy (BIV-CRT) in patients with heart failure and right bundle branch block (RBBB).
This description comes directly from the study's public registry record.
Ann Colasurdo · 585-275-1054 · ann.colasurdo@heart.rochester.edu
Mary Brown · 585-273-5283 · mary.brown@heart.rochester.edu
Always discuss trial participation with your own doctor first.
| University of Arizona | Phoenix, Arizona, United States | Recruiting |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Northwestern Memorial Hospital | Chicago, Illinois, United States | Recruiting |
| Rush University Medical Center | Chicago, Illinois, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| Valley Health System | Ridgewood, New Jersey, United States | Recruiting |
| Weill Cornell Medical College | New York, New York, United States | Recruiting |
| Mount Sinai Hospital | New York, New York, United States | Recruiting |
| Mission Health | Asheville, North Carolina, United States | Recruiting |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
| Geisinger Wyoming Valley | Wilkes-Barre, Pennsylvania, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05265520